Showing results (431-440 of 448) with videos related to

Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancerAmir Goldkorn, Benjamin Ely, David I Quinn, et al.
Clinical Genitourinary Cancer|June 6, 2017
Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421Guru Sonpavde, Gregory R Pond, Melissa Plets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
Consensus Recommendations for Disease- and Treatment-Related Fatigue in Patients With Advanced Prostate Cancer: A Modified Delphi PanelStephen J Freedland, William Aronson, Arash Asher, et al.
The Review of Scientific Instruments|February 11, 2024
Robust unfolding of MeV x-ray spectra from filter stack spectrometer dataC-S Wong, J Strehlow, D P Broughton, et al.
European Urology|December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on OutcomesMatthew D Galsky, Huan Wang, Noah M Hahn, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Cancer Discovery|January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor GrowthHubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012Maha Hussain, Stephanie Daignault-Newton, Przemyslaw W Twardowski, et al.
Pageof 45